Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
muscle relaxant |
| gptkbp:ATCCode |
M03BB03
|
| gptkbp:CASNumber |
95-25-0
|
| gptkbp:chemicalFormula |
C7H4ClNO2
|
| gptkbp:discoveredIn |
1955
|
| gptkbp:eliminationHalfLife |
1-2 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
chlorzoxazone
|
| gptkbp:IUPACName |
5-chloro-2,3-dihydro-1,3-benzoxazol-2-one
|
| gptkbp:KEGGID |
D00273
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:meltingPoint |
189-192 °C
|
| gptkbp:MeSH_ID |
D002779
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
169.57 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1431
2622 2723 DB00346 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness drowsiness liver toxicity |
| gptkbp:UNII |
OEH0V838TY
|
| gptkbp:usedFor |
muscle spasm
|
| gptkbp:bfsParent |
gptkb:Cyp2e1
gptkb:centrally_acting_muscle_relaxants gptkb:Spasma |
| gptkbp:bfsLayer |
8
|